# Jashin J. Wu

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jashin-j-wu/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,058 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 55 |
| i10-index | 246 |
| Last Known Institution | Novartis (Switzerland) |
| OpenAlex ID | https://openalex.org/A5069063369 |
| ORCID iD | 0000-0002-1722-1892 |
| Works | 720 |

## Researcher papers

- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis/)
- [Psoriasis](https://scholariq.org/papers/psoriasis/)
- [Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis](https://scholariq.org/papers/phase-3-studies-comparing-brodalumab-with-ustekinumab-in-psoriasis/)
- [Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies](https://scholariq.org/papers/prevalence-of-psoriatic-arthritis-in-patients-with-psoriasis-a-systematic-review/)
- [Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-2/)
- [Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies](https://scholariq.org/papers/joint-american-academy-of-dermatology-national-psoriasis-foundation-guidelines/)
- [Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures](https://scholariq.org/papers/joint-aad-npf-guidelines-of-care-for-the-management-and-treatment-of-psoriasis-3/)
- [Association Between Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis](https://scholariq.org/papers/association-between-tumor-necrosis-factor-inhibitor-therapy-and-myocardial/)
- [Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council](https://scholariq.org/papers/recategorization-of-psoriasis-severity-delphi-consensus-from-the-international/)
- [The association of psoriasis with autoimmune diseases](https://scholariq.org/papers/the-association-of-psoriasis-with-autoimmune-diseases/)
- [Real-World Effectiveness of Newly Initiated Systemic Therapy for Atopic Dermatitis in the United States: A Claims Database Analysis](https://scholariq.org/papers/real-world-effectiveness-of-newly-initiated-systemic-therapy-for-atopic/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Novartis (Switzerland)](https://scholariq.org/institutions/novartis-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.